4//SEC Filing
Bharucha David 4
Accession 0001415889-25-019773
CIK 0001408443other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 4:15 PM ET
Size
9.4 KB
Accession
0001415889-25-019773
Insider Transaction Report
Form 4
Bharucha David
Chief Medical Officer
Transactions
- Award
Common Shares
2025-07-11+53,333→ 63,333 total - Award
Series B Common Warrants (right to buy)
2025-07-11+53,333→ 53,333 totalExercise: $1.88Exp: 2030-07-11→ Common Shares (53,333 underlying) - Award
Series A Common Warrants (right to buy)
2025-07-11+53,333→ 53,333 totalExercise: $1.50Exp: 2026-07-11→ Common Shares (53,333 underlying)
Footnotes (2)
- [F1]The reported securities are included within 53,333 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 53,333 shares of common stock.
- [F2]Fully vested and exercisable.
Documents
Issuer
Milestone Pharmaceuticals Inc.
CIK 0001408443
Entity typeother
Related Parties
1- filerCIK 0001910985
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 4:15 PM ET
- Size
- 9.4 KB